I agree TB. And the Company is doing exactly what it said it would do - progress reports in first half of year and if results are as expected, therapeutic data pack in second half. The trading situation is as crappy as it has been for a long long time - no deal yet, long term holders, low liquidity for traders to play with.
One thing I have been happy about in the past 12 months is there is no more maybe we will produce a report and then keep delaying it. The new CEO says what he will do and then does it. So, first half we will get a readout based on 2nd gen CPP and if all good then H2 will see a long awaited therapeutic data pack.
PYC Price at posting:
2.4¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)